| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

From the Department of Internal Medicine,* Pulmonary and Critical Care Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts; and the Department of Cell Biology and Physiology,
Washington University School of Medicine, St. Louis, Missouri
Aspiration of gastric acid commonly injures airway epithelium and, if severe, can lead to respiratory failure from acute respiratory distress syndrome. Recently, we identified cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) as pivotal mediators in vivo for resolution of acid-initiated acute lung injury. To examine protective mechanisms for these mediators in the airway, we developed an in vitro model of acid injury by transiently exposing well-differentiated normal human bronchial epithelial cells to hydrochloric acid. Transmission electron microscopy revealed selective injury to superficial epithelial cells with disruption of cell attachments and cell shedding. The morphological features of injury were substantially resolved within 6 hours. Acid triggered and early marked increases in COX-2 expression and PGE2 production, and acid-induced PGE2 significantly increased epithelial LXA4 receptor (ALX) expression. LXA4 is generated in vivo during acute lung injury, and we observed that nanomolar quantities increased basal epithelial cell proliferation and potently blocked acid-triggered interleukin-6 release and neutrophil transmigration across well-differentiated normal human bronchial epithelial cells. Expression of recombinant human ALX in A549 airway epithelial cells uncovered ALX-dependent inhibition of cytokine release by LXA4. Together, these findings indicate that injured bronchial epithelial cells up-regulate ALX in a COX-2-dependent manner to promote LXA4-mediated resolution of airway inflammation.
This article has been cited by other articles:
![]() |
K. Gronert Lipid Autacoids in Inflammation and Injury Responses: A Matter of Privilege Mol. Interv., February 1, 2008; 8(1): 28 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Levy, N. W. Lukacs, A. A. Berlin, B. Schmidt, W. J. Guilford, C. N. Serhan, and J. F. Parkinson Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism FASEB J, December 1, 2007; 21(14): 3877 - 3884. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Haworth and B. D. Levy Endogenous lipid mediators in the resolution of airway inflammation Eur. Respir. J., November 1, 2007; 30(5): 980 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Parameswaran, K. Radford, A. Fanat, J. Stephen, C. Bonnans, B. D. Levy, L. J. Janssen, and P. G. Cox Modulation of Human Airway Smooth Muscle Migration by Lipid Mediators and Th-2 Cytokines Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 240 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bonnans and B. D. Levy Lipid Mediators as Agonists for the Resolution of Acute Lung Inflammation and Injury Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 201 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wallace Commonality of Defensive Roles of COX-2 in the Lung and Gut Am. J. Pathol., April 1, 2006; 168(4): 1060 - 1063. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |